Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.2540
+0.0050 (2.01%)
Sep 2, 2026, 2:35 PM EDT - Market open
Theriva Biologics Market Cap
Theriva Biologics has a market cap or net worth of $11.66 million as of September 2, 2026. Its market cap has increased by 198.89% in one year.
Market Cap
11.66M
Enterprise Value
3.87M
1-Year Change
198.89%
Ranking
Category
Stock Price
$0.25
ChartMarket Cap Chart
Since April 2, 2007, Theriva Biologics's market cap has decreased from $81.60M to $11.66M, a decrease of -85.71%. That is a compound annual growth rate of -9.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 11.66M | 64.18% |
| Dec 31, 2025 | 7.10M | 44.90% |
| Dec 31, 2024 | 4.90M | -32.88% |
| Dec 29, 2023 | 7.30M | 1.39% |
| Dec 30, 2022 | 7.20M | -79.94% |
| Dec 31, 2021 | 35.90M | 366.23% |
| Dec 31, 2020 | 7.70M | -9.41% |
| Dec 31, 2019 | 8.50M | 11.84% |
| Dec 31, 2018 | 7.60M | -88.36% |
| Dec 29, 2017 | 65.30M | -7.11% |
| Dec 30, 2016 | 70.30M | -66.19% |
| Dec 31, 2015 | 207.90M | 96.32% |
| Dec 31, 2014 | 105.90M | 55.05% |
| Dec 31, 2013 | 68.30M | -11.18% |
| Dec 31, 2012 | 76.90M | 116.62% |
| Dec 30, 2011 | 35.50M | 22.84% |
| Dec 31, 2010 | 28.90M | 140.83% |
| Dec 31, 2009 | 12.00M | 224.32% |
| Dec 31, 2008 | 3.70M | -96.22% |
| Dec 31, 2007 | 97.80M | 19.85% |
| Apr 2, 2007 | 81.60M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 12.25M |
| Daré Bioscience | 11.78M |
| PDS Biotechnology | 11.42M |
| MetaVia | 11.33M |
| Kiora Pharmaceuticals | 11.11M |
| Vistagen Therapeutics | 10.80M |
| IN8bio | 10.75M |
| Azitra | 10.71M |